HT1080 Cells
HT1080 cells are a widely used cell line in hematology and oncology research. These cells were first isolated from a human fibrosarcoma tumor in 1983 by Dr. Janet S. Butel and Dr. Janet S. Meltzer at the Baylor College of Medicine. Since then, HT1080 cells have become an important tool for studying cancer cell biology and tumor development. HT1080 cells are a type of human fibrosarcoma cell that can be grown in culture. These cells are known for their ability to invade and metastasize, making them a valuable model for studying cancer metastasis. They are also used to test the effectiveness of new cancer therapies, including chemotherapeutic drugs and immunotherapies. Researchers studying HT1080 cells have identified a number of important genes and pathways involved in cancer cell invasion and metastasis. For example, studies have shown that the overexpression of the protein S100A4 promotes invasive behavior in HT1080 cells, while the protein ARHGAP21 inhibits their ability to invade and metastasize. HT1080 cells are just one of many cell lines used in hematology and oncology research, but they have proven to be an important model for studying cancer progression and developing new therapies. With ongoing research into the biology of cancer cells, we may be able to develop more effective treatments and ultimately find a cure for this devastating disease.
← Hematology Research and Oncology Research